These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 3757258)

  • 1. Digoxin-like immunoreactive substances and bile acids in the serum of patients with liver disease.
    Pudek MR; Seccombe DW; Humphries K
    Clin Chem; 1986 Oct; 32(10):2005-6. PubMed ID: 3757258
    [No Abstract]   [Full Text] [Related]  

  • 2. Endogenous digoxin-like immunoreactive substances eliminated from serum samples from patients with liver disease by the EMIT column digoxin assay.
    Kulaots IA; Pudek MR; Seccombe DW
    Clin Chem; 1987 Aug; 33(8):1490-1. PubMed ID: 3301074
    [No Abstract]   [Full Text] [Related]  

  • 3. Bile salts as endogenous digitalis like factors.
    Vasdev SC; Longerich LL; Ittel TH; Johnson E; Barrowman JA; Gault MH
    Clin Invest Med; 1986; 9(3):201-8. PubMed ID: 3019598
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Digoxin-like immunoreactive substance (DLIS) in liver disease: comparison of clinical and laboratory parameters in patients with and without DLIS.
    Gervais A; Nanji AA; Greenway DC; McLean W
    Drug Intell Clin Pharm; 1987 May; 21(5):450-2. PubMed ID: 3582173
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Digoxin-like immunoreactive substances in the plasma of intensive care unit patients: relationship to organ dysfunction.
    Howarth DM; Sampson DC; Hawker FH; Young A
    Anaesth Intensive Care; 1990 Feb; 18(1):45-52. PubMed ID: 2159733
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Interference of digoxin-like immunoreactive substance in the analysis of digoxin in pulmonary pathology: preliminary results].
    Romano L; Zofra S; Imperato G; Adorno V; Maglione A
    Arch Monaldi; 1985; 40(3-4):157-64. PubMed ID: 3842060
    [No Abstract]   [Full Text] [Related]  

  • 7. [Digoxin-like material in liver disease].
    Shilo L; Shapiro MS; Shenkman L
    Harefuah; 1988 Mar; 114(5):224-5. PubMed ID: 3366400
    [No Abstract]   [Full Text] [Related]  

  • 8. Endogenous digoxin-like substance(s) and combined hepatic and renal failure.
    Gault MH; Vasdev SC; Longerich LL
    Ann Intern Med; 1984 Oct; 101(4):567-8. PubMed ID: 6548099
    [No Abstract]   [Full Text] [Related]  

  • 9. Digitoxin antibody cross-reactivity and evaluation of potential candidates for circulating digitalis-like immunoreactive factor.
    Graves SW; Naomi S; Williams GH; Hollenberg NK
    Clin Chem; 1994 Oct; 40(10):1977-8. PubMed ID: 7923784
    [No Abstract]   [Full Text] [Related]  

  • 10. Higher values for digitalis-like factors with TDx Digoxin II.
    Gault MH; Vasdev S; Longerich L
    Clin Chem; 1986 Oct; 32(10):2000-1. PubMed ID: 3757253
    [No Abstract]   [Full Text] [Related]  

  • 11. Influence of assay methodologies and interferences on the interpretation of digoxin concentrations.
    Fitzsimmons WE
    Drug Intell Clin Pharm; 1986; 20(7-8):538-42. PubMed ID: 3755675
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Observations on serum digoxin-like immunoreactive substances in patients with cor-pulmonale].
    Shi YS; Liu JH; Yu XZ
    Zhonghua Nei Ke Za Zhi; 1993 Mar; 32(4):229-31. PubMed ID: 8156846
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Minimizing analytical interferences from digoxin-like immunoreactive substances (DLIS) in cases of digoxin toxicity.
    Seccombe DW; Pudek MR; Humphries KH
    J Forensic Sci; 1987 May; 32(3):650-7. PubMed ID: 3598515
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of free digoxin and total digoxin: extent of interference from digoxin-like immunoreactive substances (DLIS) in a fluorescence polarization assay.
    Dasgupta A; Nakamura A; Doria L; Dennen D
    Clin Chem; 1989 Feb; 35(2):323-4. PubMed ID: 2914387
    [No Abstract]   [Full Text] [Related]  

  • 15. Endogenous digoxin-like immunoreactive substance in patients undergoing coronary surgery. Preliminary report.
    Nashef SA; Kirk AJ; Brewster N; Louden I; Percy-Robb IW; Bain WH
    Eur J Cardiothorac Surg; 1988; 2(5):380-1. PubMed ID: 3272244
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Digoxin-like immunoreactive substance in renal failure.
    Seyrek N; Paydas S; Sargin O; Günday V; Sağliker Y
    Nephron; 1994; 67(2):253-4. PubMed ID: 8072625
    [No Abstract]   [Full Text] [Related]  

  • 17. Effect of digoxin-like immunoreactive substances on the "Dac-Cel" digoxin assay.
    Smith RL
    Clin Chem; 1987 Sep; 33(9):1697. PubMed ID: 3621591
    [No Abstract]   [Full Text] [Related]  

  • 18. [Changes in serum endogenous digoxin-like substances in cirrhotic patients treated by ultrafiltration of ascites and reinfusion].
    Yang J
    Zhonghua Yi Xue Za Zhi; 1991 Jun; 71(6):329-30. PubMed ID: 1667498
    [No Abstract]   [Full Text] [Related]  

  • 19. Digoxin-like immunoreactive substance in pregnancy.
    González AR; Phelps SJ; Cochran EB; Sibai BM
    Am J Obstet Gynecol; 1987 Sep; 157(3):660-4. PubMed ID: 2820228
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Digoxin-like immunoreactive substances in urine and serum from preterm and term infants: relationship to renal excretion of sodium.
    Ebara H; Suzuki S; Nagashima K; Shimano S; Kuroume T
    J Pediatr; 1986 May; 108(5 Pt 1):760-2. PubMed ID: 3009770
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.